691856-96-9

Basic information

• Product Name: methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate
• Synonyms: methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate
• CAS NO: 691856-96-9
• Molecular Weight: 286.259
• Mol File: 691856-96-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate(691856-96-9)
• EPA Substance Registry System: methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate(691856-96-9)

Safety Data

• Hazardous Substances Data: 691856-96-9(Hazardous Substances Data)

Upstream product

• 63131-29-3 methyl 4-fluorobenzoyl acetate 
• 106-51-4 p-benzoquinone 

Downstream Products

• 1072843-89-0 methyl 5-(allyloxy)-2-(4-fluorophenyl)benzofuran-3-carboxylate 
• 1072844-14-4 2-(4-fluorophenyl)‐5‐hydroxybenzofuran‐3‐carboxylic acid 
• 1331942-87-0 methyl 2-(4-fluorophenyl)-5-[(1-methylethyl)oxy]-1-benzofuran-3-carboxylate 
• 1423007-42-4 5-cyclopropyl-6-[N-(3-fluoro-4-nitrophenyl)methanesulfonamido]-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1423007-44-6 6-[N-(4-bromo-3-fluorophenyl)methanesulfonamido]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1423007-45-7 5-cyclopropyl-6-(N-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methylsulfonamido)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide 
• 1423007-41-3 (4-{N-[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]methanesulfonamido}-2-fluorophenyl)boronic acid 
• 1423007-47-9 5-cyclopropyl-6-[N-(3-fluoro-4-nitrophenyl)methanesulfonamido]-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1423007-48-0 6-[N-(4-amino-2-fluorophenyl)methanesulfonamido]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1423007-49-1 6-[N-(4-bromo-2-fluorophenyl)methanesulfonamido]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1423007-50-4 5-cyclopropyl-6-(N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methylsulfonamido)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide 
• 1423007-46-8 (4-{N-[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]methanesulfonamido}-3-fluorophenyl)boronic acid 
• 1423007-38-8 (3-{N-[2-(4-fluorophenyl)-5-cyclopropyl-3-(methylcarbamoyl)-1-benzofuran-6-yl]methanesulfonamido}phenyl)boronic acid 
• 1423007-40-2 5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methylsulfonamido)benzofuran-3-carboxamide 

Relevant articles and documents

THERAPEUTIC METHODS

The present invention features a method for the treatment of Hepatitis C in a human in need thereof comprising administering a compound of Formulas (II) or (IIB) described herein or a pharmaceutically acceptable salt thereof in combination with one or more alternative Hepatitis C therapeutic agents

COMPOUNDS

The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.